1. Long, R., et al., Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment. Infect Control Hosp Epidemiol, 2003. 24(11): p. 831-8.
2. Moore, D.F., et al., Amplification of rRNA for assessment of treatment response of pulmonary tuberculosis patients during antimicrobial therapy. J Clin Microbiol, 1996. 34(7): p. 1745-9.
3. Telzak, E.E., et al., Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis, 1997. 25(3): p. 666-70.
4. Iinuma, Y., et al., Diagnostic value of the Amplicor PCR assay for initial diagnosis and assessment of treatment response for pulmonary tuberculosis. Microbiol Immunol, 1998. 42(4): p. 281-7.
5. Iseman, M.D., An unholy trinity–three negative sputum smears and release from tuberculosis isolation. Clin Infect Dis, 1997. 25(3): p. 671-2.
6. Department of Human Services, Victoria.,
Management, Control and Prevention of tuberculosis.
Guidelines for health care providers (2002 – 2005).
7. Guidelines for preventing the transmission of tuberculosis in Canadian Health Care Facilities and other institutional settings. Can Commun Dis Rep, 1996. 22 Suppl 1: p. i-iv, 1-50, i-iv, 1-55.
8. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. Centers for Disease Control and Prevention. MMWR Recomm Rep, 1994. 43(RR-13): p. 1-132.
9. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society. Thorax, 2000. 55(11): p. 887-901.